Abstract
Being counted as one among the top most four non-communicable diseases (NCD) in the world, diabetes is steadily increasing in incidences over the last quarter century. The change in dietary habits, sedentary lifestyles, stress, and aggravating genetic disposition factors are among the major causes of the disease. Diabetes is classified based on the pathological reasons that finally result in uncontrolled blood sugar. These include the destruction of pancreatic β-cells by autoimmune antibodies, mutational errors in insulin secretion pathway, insulin sensitivity, and drug-induced diabetes. Drugs that are effective in managing diabetes act through the modulation of specific target proteins that help in effective insulin secretion, enhancing sensitivity and reducing secondary complication. Phytochemicals are the treasure of bioactive molecules, having immense potential to prevent and cure most of the disease known till date. Antidiabetic drug molecules derived from plant sources, as well as through chemical synthesis are presently available in the market, and they possess considerable side effects in one way or another. So, molecules that could manage blood sugar better than existing is a hot topic of research. Due to alarming rise in incidence of diabetes, most of key players in drug industry are focussing to widen the range of antidiabetic drugs, identification of new targets and molecules, and combination of drugs. This chapter mainly focuses on the prospects of phytochemicals as hypoglycaemic drug and diabetes management regimen, present scenario, and scope in the modern medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- 17β-HSD1:
-
17β-hydroxysteroid dehydrogenase type 1
- ADD:
-
Antidiabetic drugs
- AMPK:
-
Adenosine monophosphate-activated protein kinase
- DAG:
-
Diacylglycerol
- EMA:
-
European Medical Association
- FFA:
-
Free fatty acid
- GFAT:
-
Glutamine fructose-6-phosphate amido transferase
- GLP1 :
-
Glucagon-like peptide-1
- GLUT:
-
Glucose transporter
- IAPP :
-
Islet amyloid polypeptide
- IDF:
-
International Diabetes Federation
- PPARγ:
-
Peroxisome proliferator-activated receptor-gamma
- PTP1B:
-
Protein tyrosine phosphatases-1B
- SGLT :
-
Sodium glucose transporter protein
- STZ:
-
Streptozotocin
- TAG:
-
Diacylglycerol
- USFDA:
-
US Food and Drug Administration
- WHO:
-
World Health Organization
References
Abbasi J (2018) Oral GLP-1 analog for type 2 diabetes on the horizon. JAMA 320:539
Abedini A, Cao P, Plesner A, Zhang J, He M, Derk J, Patil SA, Rosario R, Lonier J, Song F, Koh H, Li H, Raleigh DP, Schmidt AM (2018) RAGE binds preamyloid IAPP intermediates and mediates pancreatic beta cell proteotoxicity. J Clin Invest 128:682–698
Abramson A, Caffarel-Salvador E, Khang M, Dellal D, Silverstein D, Gao Y, Frederiksen MR, Vegge A, Hubálek F, Water JJ, Friderichsen AV, Fels J, Kirk RK, Cleveland C, Collins J, Tamang S, Hayward A, Landh T, Buckley ST, Roxhed N, Rahbek U, Langer R, Traverso G (2019) An ingestible self-orienting system for oral delivery of macromolecules. Science 363:611–615
Agarwal YO, Sharma PK, Shrivastava B, Ojha S, Upadhya HM, Arya DS, Goyal SN (2014) Hesperidin produces cardioprotective activity via PPAR-γ pathway in ischemic heart disease model in diabetic rats. PLoS One 9:e111212
Ahangarpour A, Mohammadian M, Dianat M (2012) Antidiabetic effect of hydroalcoholic Urtica dioica leaf extract in male rats with fructose-induced insulin resistance. Iran J Med Sci 37:181–186
Ahmed ABA, Rao AS, Rao MV (2010) In vitro callus and in vivo leaf extract of Gymnema sylvestre stimulate β-cells regeneration and anti-diabetic activity in Wistar rats. Phytomedicine 17:1033–1039
Akash MSH, Rehman K, Tariq M, Chen S (2015) Zingiber officinale and type 2 diabetes mellitus: evidence from experimental studies. Crit Rev Eukaryot Gene Expr 25:91–112
Akiyama S, Katsumata S, Suzuki K, Ishimi Y, Wu J, Uehara M (2010) Dietary hesperidin exerts hypoglycemic and hypolipidemic effects in streptozotocin-induced marginal type 1 diabetic rats. J Clin Biochem Nutr 46:87–92
American Diabetes Association (2013) Economic costs of diabetes in the U.S. in 2012. Diabetes Care 36:1033–1046
American Diabetes Association (2019a) Economic costs of diabetes in the U.S. in 2017. Diabetes Care 41:917–928
American Diabetes Association (2019b) Position statement on standards of medical care in diabetes—2019 abridged for primary care providers. Clin Diabetes 37:11–34
Anderson A, Walker BR (2013) 11β-HSD1 inhibitors for the treatment of type 2 diabetes and cardiovascular disease. Drugs 73:1385–1393
Andrade-Cetto A, Wiedenfeld H (2004) Hypoglycemic effect of Acosmium panamense bark on streptozotocin diabetic rats. J Ethnopharmacol 90:217–220
Aquilante CL (2010) Sulfonylurea pharmacogenomics in type 2 diabetes: the influence of drug target and diabetes risk polymorphisms. Expert Rev Cardiovasc Ther 8:359–372
Bhattacharya S, Oksbjerg N, Young JF, Jeppesen PB (2014) Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetes Obes Metab 16:602–612
Blander G, Guarnte L (2004) The Sir2 family of protein deacetylases. Annu Rev Biochem 73:417–435
Cadavez L, Montane J, Alcarraz-Vizan G, Visa M, Vidal-Fabrega L, Servitja JM, Novials A (2014) Chaperones ameliorate beta cell dysfunction associated with human islet amyloid polypeptide overexpression. PLoS One 9:e101797
Chawla A, Chawla R, Jaggi S (2016) Microvascular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab 20:546–551
Chincholkar A, Pentewar G (2017) Cost variation analysis of oral anti-diabetic agents available in drug store of the tertiary care hospital and in Indian market. Int J Basic Clin Pharmacol 6:1794–1798
Choi JH, Banks AS, Estall JL, Kajimura S, Boström P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Blüher M, Griffin PR, Spiegelman BM (2010) Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature 466:451–456
Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S (2012) Curcumin extract for prevention of type 2 diabetes. Diabetes Care 35:2121–2127
Das UN (1999) GLUT-4, tumor necrosis factor, essential fatty acids and daf-genes and their role in insulin resistance and non-insulin dependent diabetes mellitus. Prostaglandins Leukot Essent Fat Acids 60:13–20
Dhanya R, Arun KB, Syama HP, Nisha P, Sundaresan A, Santhosh Kumar TR, Jayamurthy P (2014) Rutin and quercetin enhance glucose uptake in L6 myotubes under oxidative stress induced by tertiary butyl hydrogen peroxide. Food Chem 158:546–554
Duwaerts CC, Maher JJ (2019) Macronutrients and the adipose-liver axis in obesity and fatty liver. Cell Mol Gastroenterol Hepatol 7:749–761
Eidi A, Eidi M, Esmaeili E (2006) Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine 13:624–629
Etxeberria U, de la Garza AL, Campión J, Martínez JA, Milagro FI (2012) Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha amylase. Expert Opin Ther Targets 16:269–297
Florence NT, Benoit MZ, Jonas K, Alexandra T, Desire DD, Pierre K, Theophile D (2014) Antidiabetic and antioxidant effects of Annona muricata (Annonaceae), aqueous extract on streptozotocin-induced diabetic rats. J Ethnopharmacol 151:784–790
Ghazali NA, Elmy A, Yuen LC, Sani NZ, Das S, Suhaimi F, Yusof R, Yusoff NH, Thent ZC (2016) Piper betel leaves induces wound healing activity via proliferation of fibroblasts and reducing 11β hydroxysteroid dehydrogenase-1 expression in diabetic rat. J Ayurveda Integr Med 7:198–208
Ghosh S, More P, Derle A, Patil AB, Markad P, Asok A, Kumbhar N, Shaikh ML, Ramanamurthy B, Shinde VS, Dhavale DD, Chopade BA (2014) Diosgenin from Dioscorea bulbifera: novel hit for the treatment of type II diabetes mellitus with inhibitory activity against α-amylase and α-glucosidase. PLoS One 9:e106039. https://doi.org/10.1371/journal.pone.0106039
Global anti-diabetic drugs market research report 2019 (2019). https://www.wiseguyreports.com/reports/3825670-global-anti-diabetic-drugs-market-research-report2019
Godinho R, Mega C, Edite TL, Carvalho E, Teixeria F, Fernandes R, Reis F (2015) The place of dipeptidyl peptidase-4 inhibitors in type 2 diabetes therapeutics: a “me too” or “the special one” antidiabetic class? J Diabetes Res 2015:806979
Governa P, Baini G, Borgonetti V, Cettolin G, Giachetti D, Magnano AR, Miraldi E, Biagi M (2018) Phytotherapy in the management of diabetes: a review. Molecules 23:105
Gunawan-Puteri MD, Kato E, Kawabata J (2012) α-Amylase inhibitors from an Indonesian medicinal herb, Phyllanthus urinaria. J Sci Food Agric 92:606–609
Hafizur RM, Hameed A, Shukrana M, Raza SA, Chishti S, Kabir N, Siddiqui RA (2015) Cinnamic acid exerts anti-diabetic activity by improving glucose tolerance in vivo and by stimulating insulin secretion in vitro. Phytomedicine 22:297–300
Hampp C, Borders-Hemphill V, Moeny DG, Wysowski DK (2014) Use of antidiabetic drugs in the U.S., 2003–2012. Diabetes Care 37:1367–1374
Hegazy GA, Alnoury AM, Gad HG (2013) The role of Acacia arabica extract as an antidiabetic, antihyperlipidemic, and antioxidant in streptozotocin-induced diabetic rats. Saudi Med J 34:727–733
Hermayer KL, Dake A (2016) Newer oral and noninsulin therapies to treat type 2 diabetes mellitus. Cleve Clin J Med 83(5 Suppl 1):S18–S26
Heymsfield SB, Wadden TA (2017) Mechanisms, pathophysiology, and management of obesity. N Engl J Med 376:254–266
Hinnen D (2017) Glucagon-like peptide 1 receptor agonists for type 2 diabetes. Diabetes Spec 30:202–210
Hossain CM, Ghosh MK, Satapathy BS, Dey NS, Mukherjee B (2014) Apigenin causes biochemical modulation, glut4 and cd38 alterations to improve diabetes and to protect damages of some vital organs in experimental diabetes. Am J Pharmacol Toxicol 9:39–52
India State-Level Disease Burden Initiative Diabetes Collaborators (2018) The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health 6:e1352–e1362
International Diabetes Federation (2017) IDF Diabetes Atlas, 8th edn. International Diabetes Federation, Brussels. http://diabetesatlas.org/resources/2017-atlas.html
Jaiswal YS, Tatke PA, Gabhe SY, Vaidya AB (2016) Antidiabetic activity of extracts of Anacardium occidentale Linn. leaves on n-streptozotocin diabetic rats. J Tradit Complement Med 7:421–427
Jones DS, Podolsky SH, Greene JA (2012) The burden of disease and the changing task of medicine. N Engl J Med 366:2333–2338
Joshi T, Singh AK, Haratipur P, Sah AN, Pandey AK, Naseri R, Juyal V, Farzaei MH (2019) Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications. J Cell Physiol 234:17212–17231
Kairupan TS, Chenga K-C, Asakawaa A, Amitania H, Yagic T, Atakaa K, Rokota NT, Kapantowd NH, Katoe I, Inui A (2019) Rubiscolin-6 activates opioid receptors to enhance glucose uptake in skeletal muscle. J Food Drug Anal 27:266–274
Kalra S, Kesavadev J, Chadha M, Kumar GV (2018) Sodium-glucose cotransporter-2 inhibitors in combination with other glucose-lowering agents for the treatment of type 2 diabetes mellitus. Indian J Endocr Metab 22:827–836
Kanaujia A, Duggar R, Pannakal ST, Yadav SS, Katiyar CK, Bansal V, Anand S, Sujatha S, Lakshmi BS (2010) Insulinomimetic activity of two new gallotannins from the fruits of Capparis moonii. Bioorg Med Chem 18:3940–3945
Khan MF, Dixit P, Jaiswal N, Tamrakar AK, Srivastava AK, Maurya R (2012) Chemical constituents of Kigelia pinnata twigs and their GLUT4 translocation modulatory effect in skeletal muscle cells. Fitoterapia 83:125–129
Kidane Y, Bokrezion T, Mebrahtu J, Mehari M, Gebreab YB, Fessehaye N, Achila OO (2018) In Vitro inhibition of α-amylase and α-glucosidase by extracts from Psiadia punctulata and Meriandra bengalensis. Evid Based Complement Alternat Med 16:2164345
Kim JS, Kwon CS, Son KH (2000) Inhibition of alpha-glucosidase and amylase by luteolin, a flavonoid. Biosci Biotechnol Biochem 64:2458–2461
Kim JH, Pan JH, Cho HT, Kim YJ (2016) Black ginseng extract counteracts streptozotocin-induced diabetes in mice. PLoS One 11:e0146843. https://doi.org/10.1371/journal.pone.0146843
Koupy D, Kotolova H, Kucerova JR (2015) Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus II. Fenugreek (Trigonella foenum-graecum). Ceska Slov Farm 64:67–71
Kumar A, Gnananath K, Gande S, Goud E, Rajesh P, Nagarjuna S (2011) Anti-diabetic activity of ethanolic extract of Achyranthes aspera leaves in streptozotocin induced diabetic rats. J Pharm Res 4:3124–3125
Lee JO, Lee SK, Kim JH, Kim N, You GY, Moon JW, Kim SJ, Park SH, Kim HS (2012) Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated Cbl/CAP signaling in 3T3-L1 preadipocyte cells. J Biol Chem 287:44121–44129
Loviscach M, Rehman N, Carter L, Mudaliar S, Mohadeen P, Ciaraldi TP, Veerkamp JH, Henry RR (2000) Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia 43:304–311
Malandrucco I, Pasqualetti P, Giordani I (2012) Very-low-calorie diet: a quick therapeutic tool to improve beta cell function in morbidly obese patients with type 2 diabetes. Am J Clin Nutr 95:609–613
Malini P, Kanchana G, Rajadurai M (2011) Antidiabetic efficacy of ellagic acid in streptozotocin induced diabetes mellitus in albino wistar rats. Asian J Pharmaceut Clin Res 4:124–128
Meng S, Cao J, Feng Q, Peng J, Hu Y (2013) Roles of chlorogenic acid on regulating glucose and lipids metabolism: a review. Evid base Compl Alternative Med 2013:801457. https://doi.org/10.1155/2013/801457
Mishra S, Singh AS, Mishra N, Pandey H, Tiwari VK (2017) Carbohydrate-based antidiabetic agents from nature. In: Brahmachari G (ed) Discovery and development of antidiabetic agents from natural products. Elsevier, Amsterdam, pp 147–183
Montane J, de Pablo S, Obach M, Cadavez L, Castano C, Alcarraz Vizan G, Visa M, Rodriguez-Comas J, Parrizas M, Servitja JM, Novials A (2016) Protein disulfide isomerase ameliorates beta-cell dysfunction in pancreatic islets over expressing human islet amyloid polypeptide. Mol Cell Endocrinol 420:57–65
Montane J, de Pablo S, Castano C, Rodriguez-Comas J, Cadavez L, Obach M, Visa M, Alcarraz-Vizan G, Sanchez Martinez M, Nonell-Canals A, Parrizas M, Servitja JM, Novials A (2017) Amyloid-induced beta-cell dysfunction and islet inflammation are ameliorated by 4-phenylbutyrate (PBA) treatment. FASEB J 31:5296–5306
Montvida O, Shaw J, Atherton JJ, Stinger F, Paul SK (2018) Long-term trends in antidiabetes drug usage in the U.S.: real-world evidence in patients newly diagnosed with type 2 diabetes. Diabetes Care 41:69–78
Morgan BJ, Sy C, Albiston AL (2011) GLUT4 associated proteins as therapeutic targets for diabetes. Recent Pat Endocr Metab Immune Drug Discov 5:25–32
Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Markle JM, Hegele RA, Huff MW (2009) Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 58:2198–2210
Nanni V, Canuti L, Gismondi A, Canini A (2018) Hydroalcoholic extract of Spartium junceum L flowers inhibits growth and melanogenesis in B16-F10 cells by inducing seneacence. Phytomedicine 46:1–10
Narasimhan A, Chinnaiyan M, Karunadevi B (2015) Ferulic acid exerts its antidiabetic effect by modulating insulin-signalling molecules in the liver of high-fat diet and fructose-induced type-2 diabetic adult male rat. Appl Physiol Nutr Metab 40:769–781
Nauck MA (2014) Update on developments with SGLT2 inhibitors in the management of type 2 diabetes. Drug Des Devel Ther 8:1335–1380
Nauck MA, Meier JJ (2016) The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions. Lancet Diabetes Endocrinol 4:525–536
Nguyen NDT, Le LT (2012) Targeted proteins for diabetes drug design. Adv Nat Sci Nanosci Nanotechnol 3:013001. https://doi.org/10.1088/2043-6262/3/1/013001
Olaokun OO, McGaw LJ, Eloff JN, Naidoo V (2013) Evaluation of the inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes. Evid Based Complement Alternat Med 13:2–12
Ong KW, Hsu A, Tan BKH (2013) Anti-diabetic and anti-lipidemic effects of chlorogenic acid are mediated by AMPK activation. Biochem Pharmacol 85:1341–1351
Oskarsson ME, Hermansson E, Wang Y, Welsh N, Presto J, Johansson J, Westermark GT (2018) BRICHOS domain of Bri2 inhibits islet amyloid polypeptide (IAPP) fibril formation and toxicity in human beta cells. Proc Natl Acad Sci U S A 115:E2752–E2761
Palanisamy S, Yien ELH, Shi LW, Si LY, Qi SH, Ling LSC, Lun TW, Chen YN (2018) Systematic review of efficacy and safety of newer antidiabetic drugs approved from 2013 to 2017 in controlling HbA1c in diabetes patients. Pharmacy (Basel) 6:57
Palsamy P, Sivakumar S, Subramanian S (2010) Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin–nicotinamide-induced experimental diabetic rats. Chem Biol Interact 186:200–210
Panunti B, Jawa AA, Fonseca VA (2004) Mechanisms and therapeutic targets in type 2 diabetes mellitus. Drug Discov Today Dis Mech 1:151–157
Paoli P, Cirri P, Caselli A, Ranaldi F, Bruschi G, Santi A, Camici G (2013) The insulin-mimetic effect of morin: a promising molecule in diabetes treatment. Biochim Biophys Acta 30:3102–3111
Park J-S, Yang J-S, Hwang B-Y, Yoo B-K, Han K (2009) Hypoglycemic effect of yacon tuber extract and its constituent, chlorogenic acid, in streptozotocin-induced diabetic rats. Biomol Ther 17:256–262
Patane G, Piro S, Rabuazzo AM, Anello M, Vigneri R, Purrello F (2000) Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 49:735–740
Pathak R, Bridgeman MB (2010) Dipeptidyl peptidase-4 (DPP-4) inhibitors in the management of diabetes. Pharm Therap 35:509–513
Pérez López G, González Albarrán O, Cano Megías M (2010) Type 2 sodium-glucose cotransporter (SGLT2) inhibitors: from familial renal glucosuria to the treatment of type 2 diabetes mellitus. Nefrologia 30:618–625
Poovitha S, Parani M (2016) In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.). BMC Complement Altern Med 16(Suppl 1):185
Popkin BM, Hawkes C (2016) Sweetening of the global diet, particularly beverages: patterns, trends, and policy responses. Lancet Diabetes Endocrinol 4:174–186
Popov D (2011) Novel protein tyrosine phosphatase 1B inhibitors: interaction requirements for improved intracellular efficacy in type 2 diabetes mellitus and obesity control. Biochem Biophys Res Commun 410:377–381
Priscilla DH, Roy D, Suresh A, Kumar V, Thirumurugan K (2014) Naringenin inhibits α-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats. Chem Biol Interact 210:77–85
Puppala M, Ponder J, Suryanarayana P, Reddy GB, Petrash M, Labarbera DV (2012) The isolation and characterisation of β-glucogallin as a novel aldose reductase inhibitor form Emblica officinalis. PLoS One 4:e31399
Qian Y, Ahmad M, Chen S, Gillespie P, Le N, Mennona F, Mischke S, So SS, Wang H, Burghardt C, Tannu S, Conde-Knape K, Kochan J, Bolin D (2011) Discovery of 1-arylcarbonyl-6,7-dimethoxyisoquinoline derivatives as glutamine fructose-6-phosphate amidotransferase (GFAT) inhibitors. Bioorg Med Chem Lett 21:6264–6269
Rawshani A, Rawshani A, Franzén S, Eliasson B, Svensson A-M, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbjörnsdottir S (2017) Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 376:1407–1418
Rojas J, Roberto A, Sofía MM, Maricarmen C, Juan S, José CM, Edward R, Sandra W-D, Marco C, Carlos G, Modesto G-R, Julio CV, Juan H, Valmore B (2016) A tale about perfect partners: new horizons in glimepiride and metformin - mechanisms of action. Archivos Venezolanos deFarmacología y Terapéutica 35:53–66
Salimifar M, Fatehi-Hassanabad Z, Fatehi M (2013) A review on natural products for controlling type 2 diabetes with an emphasis on their mechanisms of actions. Curr Diabetes Rev 9:402–411
Samuel VT, Shulman GI (2016) The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest 126:12–22
Sangeetha KN, Sujatha S, Muthusamy VS, Anand S, Nithya N, Velmurugan D, Balakrishnan A, Lakshmi BS (2010) 3β-taraxerol of Mangifera indica, a PI3K dependent dual activator of glucose transport and glycogen synthesis in 3T3-L1 adipocytes. Biochim Biophys Acta 1800:359–366
Sarian MN, Ahmed QU, Mat So’ad SZ, Alhassan AM, Murugesu S, Perumal V, Syed Mohamad SNA, Khatib A, Latip J (2017) Antioxidant and antidiabetic effects of flavonoids: a structure-activity relationship based study. Biomed Res Int 2017:8386065. https://doi.org/10.1155/2017/8386065
Sendrayaperumal V, Iyyam Pillai S, Subramanian S (2014) Design, synthesis and characterization of zinc-morin, a metal flavonol complex and evaluation of its antidiabetic potential in HFD-STZ induced type 2 diabetes in rats. Chem Biol Interact 219:9–17
Sharma AK, Bharti S, Goyal S, Arora S, Nepal S, Kishore K, Joshi S, Kumari S, Arya DS (2011) Upregulation of PPAR by Aegle marmelos ameliorates insulin resistance and -cell dysfunction in high fat diet fed-streptozotocin induced type 2 diabetic rats. Phytother Res 25:1457–1465
Sharma A, Green JB, Dunning A, Lokhnygina Y, Al-Khatib SM, Lopes RD, Buse JB, Lachin JM, Van de Werf F, Armstrong PW, Kaufman KD, Standl E, Chan JCN, Distiller LA, Scott R, Peterson ED, Holman RR, TECOS Study Group (2017) Causes of death in a contemporary cohort of patients with type 2 diabetes and atherosclerotic cardiovascular disease: insights from the TECOS trial. Diabetes Care 40:1763–1770
Singh N, Gupta M (2007) Regeneration of β cells in islets of Langerhans of pancreas of alloxan diabetic rats by acetone extract of Momordica charantia (Linn.) (bitter gourd) fruits. Indian J Exp Bio 45:1055–1062
Sridharan K, Mohan R, Ramaratnam S, Panneerselvam D (2011) Ayurvedic treatments for diabetes mellitus. Cochrane Database Syst Rev 12:CD008288
Sunil C, Ignacimuthu S, Agastian P (2011) Antidiabetic effect of Symplocos cochinchinensis (Lour.) S. Moore. in type 2 diabetic rats. J Ethnopharmacol 134:298–304
Szkudelski T, Szkudelska K (2011) Anti-diabetic effects of resveratrol. Ann N Y Acad Sci 1215:34–39
Taylor R (2012) Insulin resistance and type 2 diabetes. Diabetes 61:778–779
Thomford NE, Senthebane DA, Rowe A, Munro D, Seele P, Maroyi A, Dzobo K (2018) Natural products for drug discovery in the 21st century: innovations for novel drug discovery. Int J Mol Sci 19:1578. https://doi.org/10.3390/ijms19061578
Tiwari N, Thakur AK, Kumar V, Dey A, Kumar V (2014) Therapeutic targets for diabetes mellitus: an update. Clin Pharmacol Biopharm 3:117. https://doi.org/10.4172/2167-065X.1000117
Vanitha P, Uma C, Suganya N, Bhakkiyalakshmi E, Suriyanarayanan S, Gunasekaran P, Sivasubramanian S, Ramkumar KM (2014) Modulatory effects of morin on hyperglycemia by attenuating the hepatic key enzymes of carbohydrate metabolism and β-cell function in streptozotocin-induced diabetic rats. Environ Toxicol Pharmacol 37:326–335
Variya BC, Bakrania AK, Patel SS (2019) Antidiabetic potential of gallic acid from Emblica officinalis: improved glucose transporters and insulin sensitivity through PPAR-γ and Akt signalling. Phytomedicine:152906. https://doi.org/10.1016/j.phymed.2019.152906
Vasilakou D, Karagiannis T, Athanasiadou E, Mainou M, Liakos A, Bekiari E, Sarigianni M, Matthews DR, Tsapas A (2013) Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med 159:262–274
Vetere A, Choudhary A, Burns SM, Wagner BK (2014) Targeting the pancreatic β-cell to treat diabetes. Nat Rev Drug Discov 13:278–289
WHO report on definition, diagnosis and classification of diabetes mellitus and its complications (1999) Department of Noncommunicable Disease Surveillance, World Health Organization. https://apps.who.int/iris/bitstream/handle/10665/66040/WHO_NCD_NCS_99.2.pdf?sequence=1
Xiang L, Huang X, Chen L, Rao P, Ke L (2007) The reparative effects of Momordica Charantia Linn. extract on HIT-T15 pancreatic β-cells. Asia Pacific J Clin Nutr 16:249–252
Zhang D, Leung PS (2014) Potential roles of GPR120 and its agonists in the management of diabetes. Drug Des Devel Ther 8:1013–1027
Zhang Y, Feng F, Chen T, Li Z, Shen QW (2016) Antidiabetic and antihyperlipidemic activities of Forsythia suspensa (Thunb.) Vahl (fruit) in streptozotocin-induced diabetes mice. J Ethnopharmacol 192:256–263
Zhou J, Chan L, Zhou S (2012) Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem 19:3523–3531
Zhu C (2013) Aldose reductase inhibitors as potential therapeutic drugs of diabetic complications. In: Oguntibeju OO (ed) Diabetes mellitus—insights and perspectives. IntechOpen, London. https://doi.org/10.5772/54642
Zou C, Li W, Pan Y, Khan ZA, Li J, Wu X, Wang Y, Deng L, Liang G, Zhao Y (2017) 11β-HSD1 inhibition ameliorates diabetes-induced cardiomyocyte hypertrophy and cardiac fibrosis through modulation of EGFR activity. Oncotarget 8:96263–96275
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Krishna, M.S., Arun, K.B. (2020). Antidiabetic Phytochemicals and Their Applications in Modern Medicine. In: Swamy, M. (eds) Plant-derived Bioactives. Springer, Singapore. https://doi.org/10.1007/978-981-15-1761-7_11
Download citation
DOI: https://doi.org/10.1007/978-981-15-1761-7_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-1760-0
Online ISBN: 978-981-15-1761-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)